News

Asieris Announces Completion of Enrollment for its US APL-1202 Phase Ib Clinical Trial

Asieris’s Executives to Participate in the Upcoming Asia Pharma R&D Leaders Summit 2019

Asieris CEO to Host CEO Roundtable at Upcoming WuXi Healthcare Forum 2019

Asieris to Participate in the Upcoming 12th European Life Sciences CEO Forum

Asieris Announced Appointment of Dr. Gail Brown as Acting Chief Medical Officer

Asieris Awarded Best Poster at AUA 2018 Annual Meeting

Asieris Announced Follow-on Investment to its B Round Funding

Asieris Announced Appointment of Dr. Yijun Deng as VP of New Drug Discovery

Notice of Relocation of Our Shanghai Office

Asieris Pharmaceuticals Invited to be a Panelist at the APRDL 2018